Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Opposition Disagrees with Reappointment of Prof. Maeda as Chuikyo Member
March 9, 2009
- Data from Ranbaxy Plant Are Falsified: FDA
March 9, 2009
- Chugai's Avastin Should Be Indicated for Stomach Cancer
March 9, 2009
- Tasigna Recommended in 2nd-Line Therapy: Prof. Ohyashiki
March 9, 2009
- Constipation Should Be Treated by Physicians: Dr Hongo
March 9, 2009
- Clinical Trial Operations Streamlined at Pfizer Japan
March 9, 2009
- Eisai to Create Independent Units in 6 Fields to Accelerate Development
March 9, 2009
- Increased Dose of Amlodipine Approved
March 9, 2009
- Daiichi Sankyo Pursues Optimal Promotion Mixes
March 9, 2009
- Astellas to Diversify Development Programs
March 9, 2009
- Teva-Kowa Aims at Becoming a Leading GE Maker in Japan in 2015
March 9, 2009
- R&D NEWS IN BRIEF
March 9, 2009
- Shire Enters Japanese Market by Opening Office in Tokyo
March 9, 2009
- BUSINESS NEWS IN BRIEF
March 2, 2009
- Korosho Suggests Re-Pricing Based Only on Increases in Sales
March 2, 2009
- Reductions in Makers' Invoice Prices Have Not Been Sufficient
March 2, 2009
- JGA Prepares Tools for Education of MRs from Its Member Companies
March 2, 2009
- REGULATORY NEWS IN BRIEF
March 2, 2009
- MEDICAL DEVICE NEWS IN BRIEF
March 2, 2009
- Bayer Yakuhin: Wellnara for Postmenopausal Osteoporosis
March 2, 2009
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…